Dr. Scott Rocklage joined 5AM Ventures in 2003 and was a Managing Partner by 2004 where he has helped the company with his thirty years of healthcare management experience. His extensive experience includes research positions at Salutar and Catalytica, CEO of Cubist Pharmaceuticals and a number of positions as Board Chairman for companies such as Novira.
5AM Ventures is a venture capitalist firm that invests in early-stage life science companies, hence the name 5AM. Dr. Scott Rocklage spends his time at 5AM between preparing for board meetings, working with a clients management team or studying new areas of life science using his extensive background.
Each day is unique and presents him with new challenges. These challenges enable him to help business executives, scientists and physicians solve the medical challenges of the modern age, such as the ability to focus on specific types of mutations to help combat cancer.
Dr. Rocklage’s Bachelor of Science in Chemistry is from the University of California, Berkeley and his Ph.D. in Chemistry is from the Massachusetts Institute of Technology. His doctoral research was conducted underneath the Nobel laureate Richard Schrock.
With over 30 patents and 100 peer-reviewed publications, Dr. Rocklage has in-depth scientific experience that enables him to be a more effective team member at 5AM Ventures when combined with his experience managing corporations and research teams. Read more: Scott Racklage | Crunchbase and Scott Rocklage | LinkedIn
His words for entrepreneurs in all areas, not just life science, is to not be afraid to take measured risks which may have significant payoffs, not just financially but also for the good of mankind.